Answers are grounded in this paper and cite their sources.
Four new tetrahydrofuranoid lignan glycosides, (7S,8R,7′R,8′S)‐4,9,4′,7′‐tetrahydroxy‐3,3′‐dimethoxy‐7,9′‐epoxylignan 9‐O‐β‐D‐glucopyranoside (2), (7R,8S,7′S,8′R)‐4,9,4′,7′‐tetrahydroxy‐3,3′‐dimethoxy‐7,9′‐epoxylignan 9‐O‐β‐D‐glucopyranoside (3), (7R,8S,7′R,8′S)‐4,9,4′,9′‐tetrahydroxy‐3,3′‐dimethoxy‐7,7′‐epoxylignan 9‐O‐β‐D‐glucopyranoside (4), and rel‐(7R,8S,7′S,8′R)‐4,9,4′,9′‐tetrahydroxy‐3,3′‐dimethoxy‐7,7′‐epoxylignan 9‐O‐β‐D‐glucopyranoside (5), and ten known lignan glycosides, 1 and 6–14, were isolated from the leaves of Osmanthus fragrans Lour. var. aurantiacus Makino. Their structures were established on the basis of spectral and chemical studies.
No takes yet. Share an insight, caveat, or question.
Machida et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: